Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS)

Related Keywords

Boston ,Massachusetts ,United States , ,Praxis Precision Medicines Inc ,Nasdaq ,Linkedin ,Compensation Committee Of Praxi Board Directors ,Facebook ,Precision Medicines ,Compensation Committee ,Praxi Board ,Praxis Precision Medicines ,Nasdaq Listing Rule ,Nasdaq Global Select Market ,Investor Contact ,Dan Ferry Life Science Advisors ,